Régimbeau J M, Panis Y, Cazaban L, Pocard M, Bouhnik Y, Matuchansky C, Valleur P
Department of Surgery, Nutritional Support, Lariboisière Hospital, Paris, France.
Colorectal Dis. 2001 Jul;3(4):232-7. doi: 10.1046/j.1463-1318.2001.00250.x.
Faecal diversion (FD) for refractory anoperineal Crohn's disease (APCD) is thought to be unsatisfactory with a low overall rate of defunctioning stoma closure. However, only a few patients have so far been reported in the literature. The aim of this study was to reassess the long-term efficiency of FD for APCD.
Among 136 patients who were operated for APCD over a 18-year period, 17 underwent FD. The factors assessed were the mortality and morbidity of stoma formation, the evolution of anoperineal Crohn's disease after FD, and predictive factors of FD effectiveness.
Mean follow-up after FD was 135 +/- 79 months (range 20-328). Initial healing of APCD was observed in 11 patients (65%), allowing stoma closure after 14 +/- 9 months (range 3-52). The 6 other patients underwent abdominoperineal resection (APR) for persistent APCD. Three of the 11 patients with normal bowel continuity underwent secondary APR for APCD recurrence. Thus, at the end of follow up 9 (53%) patients had definitive end ileostomy and 8 (47%) continued to have normal bowel continuity with a mean follow up of 124 +/- 90 months (range 12-292) after stoma closure. The presence of rectal lesions at the time of FD was the only predictive factor of poor outcome: 8/9 (89%) patients with rectal lesions underwent APR vs 1/8 (13%) patients without rectal lesion (P < 0.01).
Faecal diversion for anoperineal Crohn's disease produced a high initial rate of anoperineal lesion healing. After long-term follow-up, results of faecal diversion are good (normal bowel continuity was restored in 89%) in patients without associated rectal lesions. However, in patients with associated rectal lesions, the prospects for restoring continuity were limited, thus making faecal diversion a questionable procedure.
对于难治性肛门直肠克罗恩病(APCD),粪便转流术(FD)被认为效果不佳,造口关闭的总体成功率较低。然而,目前文献中报道的患者数量较少。本研究的目的是重新评估FD治疗APCD的长期疗效。
在18年期间接受APCD手术的136例患者中,17例接受了FD。评估的因素包括造口形成的死亡率和发病率、FD后肛门直肠克罗恩病的进展情况以及FD疗效的预测因素。
FD后的平均随访时间为135±79个月(范围20 - 328个月)。11例患者(65%)观察到APCD初始愈合,造口在14±9个月(范围3 - 52个月)后关闭。另外6例患者因持续性APCD接受了腹会阴联合切除术(APR)。11例肠道连续性正常的患者中有3例因APCD复发接受了二次APR。因此,随访结束时,9例(53%)患者有永久性末端回肠造口,8例(47%)患者肠道连续性仍正常,造口关闭后的平均随访时间为124±90个月(范围12 - 292个月)。FD时存在直肠病变是预后不良的唯一预测因素:8/9(89%)有直肠病变的患者接受了APR,而无直肠病变的患者中1/8(13%)接受了APR(P < 0.01)。
肛门直肠克罗恩病的粪便转流术使肛门直肠病变的初始愈合率较高。长期随访后,无相关直肠病变的患者粪便转流术效果良好(89%恢复了正常肠道连续性)。然而,对于有相关直肠病变的患者,恢复肠道连续性的前景有限,因此粪便转流术成为一个有疑问的手术方式。